Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission
Mitja Jevnikar, Olivier Sanchez, Richard Chocron, M. Andronikof, Maurice Raphaël, Olivier Meyrignac, Laure Fournier, David Montani, Benjamin Planquette, Mary Soudani, Athénaïs Boucly, Jérémie Pichon, Mariana Preda, Antoine Beurnier, Sophie Bulifon, Andrei Seferian, Xavier Jaïs, Olivier Sitbon, Laurent Savale, Marc Humbert, Florence Parent
Abstract
A high prevalence of venous thromboembolism (VTE) has been reported during intensive care unit (ICU) hospitalisation in patients with severe coronavirus disease 2019 (COVID-19) [1, 2]. In most cases, the diagnosis of pulmonary embolism (PE) was incidental as patients underwent computed tomography pulmonary angiography (CTPA) for aggravation of their respiratory condition. Higher mortality is also described in patients with high D-dimer levels suggesting that VTE complication may contribute to unfavourable prognosis [3, 4]. Even though, prevalence of thromboembolic complications during ICU hospitalisation seems to be high, the prevalence of pulmonary embolism at hospital admission for COVID-19 is unknown and may be underestimated. There is a high prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission <https://bit.ly/3reaLjv>